Remove trial restrictions ▶ Start for $1

Serving leading biopharmaceutical companies globally:

Harvard Business School
McKesson
AstraZeneca
McKinsey
Moodys
Medtronic

Last Updated: May 21, 2022

Strides Pharma Company Profile


✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for STRIDES PHARMA, and what generic and branded alternatives to STRIDES PHARMA drugs are available?

STRIDES PHARMA has two hundred and forty-seven approved drugs.



Summary for Strides Pharma
US Patents:0
Tradenames:154
Ingredients:150
NDAs:247
Patent Litigation for Strides Pharma: See patent lawsuits for Strides Pharma

Drugs and US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Strides Pharma MOBAN molindone hydrochloride TABLET;ORAL 017111-008 Approved Prior to Jan 1, 1982 DISCN Yes No See Plans and Pricing See Plans and Pricing
Strides Pharma PROMETHAZINE HYDROCHLORIDE promethazine hydrochloride TABLET;ORAL 209177-001 Jun 30, 2017 AB RX No No See Plans and Pricing See Plans and Pricing
Strides Pharma OMEPRAZOLE AND SODIUM BICARBONATE omeprazole; sodium bicarbonate FOR SUSPENSION;ORAL 079182-002 Apr 19, 2013 AB RX No No See Plans and Pricing See Plans and Pricing
Strides Pharma MYCOPHENOLATE MOFETIL mycophenolate mofetil CAPSULE;ORAL 090055-001 Jun 10, 2010 AB RX No No See Plans and Pricing See Plans and Pricing
Strides Pharma CYPROHEPTADINE HYDROCHLORIDE cyproheptadine hydrochloride TABLET;ORAL 209172-001 Apr 11, 2018 AA RX No No See Plans and Pricing See Plans and Pricing
Strides Pharma TENOFOVIR DISOPROXIL FUMARATE tenofovir disoproxil fumarate TABLET;ORAL 090742-001 Jan 26, 2018 AB RX No No See Plans and Pricing See Plans and Pricing
Strides Pharma AMOXICILLIN amoxicillin CAPSULE;ORAL 062884-001 Feb 25, 1988 DISCN No No See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Strides Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 6,143,775 See Plans and Pricing
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-002 Approved Prior to Jan 1, 1982 4,105,776 See Plans and Pricing
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-004 Jun 13, 1995 4,258,027 See Plans and Pricing
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-001 Sep 26, 1996 5,583,152 See Plans and Pricing
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 4,258,027 See Plans and Pricing
Strides Pharma ACCOLATE zafirlukast TABLET;ORAL 020547-003 Sep 17, 1999 4,859,692 See Plans and Pricing
Strides Pharma CAPOTEN captopril TABLET;ORAL 018343-007 Jun 13, 1995 5,238,924 See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for STRIDES PHARMA drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 10 mg and 20 mg ➤ Subscribe 2008-02-29
➤ Subscribe Delayed-release Tablets 20 mg ➤ Subscribe 2015-06-03
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
Johnson and Johnson
Boehringer Ingelheim
Mallinckrodt
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.